Literature DB >> 23318104

Evaluation of antioxidant treatment in presbyacusis: prospective, placebo-controlled, double-blind, randomised trial.

J F Polanski1, O L Cruz1.   

Abstract

OBJECTIVE: There are many well-known aetiological mechanisms of presbyacusis, and free radicals have been shown to play an important role. This study aimed to evaluate the effect of antioxidant agents on the hearing threshold of patients with presbyacusis.
METHODS: One hundred and twenty individuals were divided into four groups and received one of the following treatment schemes: ginkgo biloba dry extract, α-lipoic acid plus vitamin C, papaverine chlorhydrate plus vitamin E, or placebo. All participants were evaluated at recruitment and after six months, using pure tone audiometry (at isolated and average frequencies), speech recognition threshold and percentage index of speech recognition.
RESULTS: The various treatments had no effect on any of the evaluated measures of hearing, either between groups or over time.
CONCLUSION: There was no statistically significant change in the hearing threshold after treatment with any of the tested drugs, during the study period.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23318104     DOI: 10.1017/S0022215112003118

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  14 in total

Review 1.  Role of antioxidants in prevention of age-related hearing loss: a review of literature.

Authors:  Elham Tavanai; Ghassem Mohammadkhani
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-11-17       Impact factor: 2.503

2.  Protective Effects of Silymarin Against Age-Related Hearing Loss in an Aging Rat Model.

Authors:  Elham Tavanai; Ghassem Mohammadkhani; Saeid Farahani; Shohreh Jalaie
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-03-14

3.  Associations between dietary quality, noise, and hearing: data from the National Health and Nutrition Examination Survey, 1999-2002.

Authors:  C Spankovich; C G Le Prell
Journal:  Int J Audiol       Date:  2014-06-30       Impact factor: 2.117

Review 4.  Translational implications of the interactions between hormones and age-related hearing loss.

Authors:  R D Frisina; P Bazard; M Bauer; J Pineros; X Zhu; B Ding
Journal:  Hear Res       Date:  2020-10-15       Impact factor: 3.208

5.  A New Approach to Treating Neurodegenerative Otologic Disorders.

Authors:  Walter H Moos; Douglas V Faller; Ioannis P Glavas; David N Harpp; Michael H Irwin; Iphigenia Kanara; Carl A Pinkert; Whitney R Powers; Kosta Steliou; Demetrios G Vavvas; Krishna Kodukula
Journal:  Biores Open Access       Date:  2018-07-01

Review 6.  Adjuvant Therapies in Diabetic Retinopathy as an Early Approach to Delay Its Progression: The Importance of Oxidative Stress and Inflammation.

Authors:  Ricardo Raúl Robles-Rivera; José Alberto Castellanos-González; Cecilia Olvera-Montaño; Raúl Alonso Flores-Martin; Ana Karen López-Contreras; Diana Esperanza Arevalo-Simental; Ernesto Germán Cardona-Muñoz; Luis Miguel Roman-Pintos; Adolfo Daniel Rodríguez-Carrizalez
Journal:  Oxid Med Cell Longev       Date:  2020-03-11       Impact factor: 6.543

Review 7.  Cochlear Inflammaging in Relation to Ion Channels and Mitochondrial Functions.

Authors:  Parveen Bazard; Jennifer Pineros; Robert D Frisina; Mark A Bauer; Alejandro A Acosta; Lauren R Paganella; Dominika Borakiewicz; Mark Thivierge; Freyda L Mannering; Xiaoxia Zhu; Bo Ding
Journal:  Cells       Date:  2021-10-15       Impact factor: 6.600

Review 8.  Age-related hearing impairment and the triad of acquired hearing loss.

Authors:  Chao-Hui Yang; Thomas Schrepfer; Jochen Schacht
Journal:  Front Cell Neurosci       Date:  2015-07-27       Impact factor: 5.505

Review 9.  Presbycusis: An Update on Cochlear Mechanisms and Therapies.

Authors:  Jing Wang; Jean-Luc Puel
Journal:  J Clin Med       Date:  2020-01-14       Impact factor: 4.241

10.  Role of melatonin in prevention of age-related hearing loss.

Authors:  Lucieny Silva Martins Serra; Juliana Gusmão de Araújo; Ana Luiza Sarkis Vieira; Eduardo Magalhães da Silva; Rafael Rocha de Andrade; Selma Aparecida Souza Kückelhaus; André Luiz Lopes Sampaio
Journal:  PLoS One       Date:  2020-02-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.